Overview

Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty

Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to compare the efficacy of two prophylactic agent(aspirin 300mg/day and rivaroxaban 10mg/day) for venous thromboembolism after total knee arthroplasty.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Hanyang University Seoul Hospital
Treatments:
Aspirin
Rivaroxaban
Criteria
Inclusion Criteria:

- all patients undergone primary total knee arthroplasty

Exclusion Criteria:

- renal insufficiency, contrast allergy, simultaneous bilateral TKA, hemorrhagic
disorder, sever liver disease